Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.31079 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.27319 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.27419 | 52 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15526 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.26621 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.39982 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.27819 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.27277 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.24852 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.36858 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.26893 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.20551 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.23451 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.27194 | 52 |